351 related articles for article (PubMed ID: 32023284)
1. The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
Amendola A; Sberna G; Forbici F; Abbate I; Lorenzini P; Pinnetti C; Antinori A; Capobianchi MR
PLoS One; 2020; 15(2):e0228192. PubMed ID: 32023284
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.
Re MC; Vitone F; Biagetti C; Schiavone P; Alessandrini F; Bon I; de Crignis E; Gibellini D
Clin Microbiol Infect; 2010 Jun; 16(6):640-6. PubMed ID: 19732081
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with
Sberna G; Sarti S; Cicalini S; Antinori A; Garbuglia AR; Amendola A
Microbiol Spectr; 2022 Oct; 10(5):e0136122. PubMed ID: 36066258
[TBL] [Abstract][Full Text] [Related]
4. Virological characterization of HIV-1 RNA elements detected exclusively through the LTR region by the dual-target Aptima HIV-1 Quant Dx assay in a subset of positive patients.
Sberna G; Nardacci R; Berno G; Rozera G; Giombini E; Fabeni L; Specchiarello E; Maggi F; Amendola A
J Clin Virol; 2023 Oct; 167():105575. PubMed ID: 37598634
[TBL] [Abstract][Full Text] [Related]
5. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.
Mohey R; Jørgensen LB; Møller BK; Black FT; Kjems J; Obel N
J Clin Virol; 2005 Dec; 34(4):257-67. PubMed ID: 16286049
[TBL] [Abstract][Full Text] [Related]
6. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection.
Brussel A; Mathez D; Broche-Pierre S; Lancar R; Calvez T; Sonigo P; Leibowitch J
AIDS; 2003 Mar; 17(5):645-52. PubMed ID: 12646786
[TBL] [Abstract][Full Text] [Related]
8. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients.
Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O
AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556
[TBL] [Abstract][Full Text] [Related]
9. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
[TBL] [Abstract][Full Text] [Related]
10. Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA.
Zaccarelli M; Santoro MM; Armenia D; Borghi V; Gennari W; Gori C; Forbici F; Bertoli A; Fabeni L; Giannetti A; Cicalini S; Bellagamba R; Andreoni M; Mastroianni CM; Mussini C; Ceccherini-Silberstein F; Perno CF; Antinori A
J Clin Virol; 2016 Sep; 82():94-100. PubMed ID: 27472519
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens.
Nicastri E; Palmisano L; Sarmati L; D'Ettorre G; Parisi S; Andreotti M; Buonomini A; Pirillo FM; Narciso P; Bellagamba R; Vullo V; Montano M; Di Perri G; Andreoni M
Curr HIV Res; 2008 May; 6(3):261-6. PubMed ID: 18473790
[TBL] [Abstract][Full Text] [Related]
12. A quantitative PCR method for the assay of HIV-1 provirus load in peripheral blood mononuclear cells.
Bennett JM; Kaye S; Berry N; Tedder RS
J Virol Methods; 1999 Dec; 83(1-2):11-20. PubMed ID: 10598078
[TBL] [Abstract][Full Text] [Related]
13. Application of a commercial kit for detection of PCR products to quantification of human immunodeficiency virus type 1 RNA and proviral DNA.
Lin HJ; Haywood M; Hollinger FB
J Clin Microbiol; 1996 Feb; 34(2):329-33. PubMed ID: 8789009
[TBL] [Abstract][Full Text] [Related]
14. Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Thim PT; Pedersen BK; Gerstoft J; Ullum H
J Infect Dis; 2005 Feb; 191(3):348-57. PubMed ID: 15633093
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
16. Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment.
Armenia D; Zaccarelli M; Borghi V; Gennari W; Di Carlo D; Giannetti A; Forbici F; Bertoli A; Gori C; Fabeni L; Pinnetti C; Marocco R; Latini A; Ceccherini-Silberstein F; Mastroianni CM; Mussini C; Antinori A; Perno CF; Santoro MM
J Clin Virol; 2018 Jul; 104():61-64. PubMed ID: 29738896
[TBL] [Abstract][Full Text] [Related]
17. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals.
Berry N; Ariyoshi K; Jobe O; Ngum PT; Corrah T; Wilkins A; Whittle H; Tedder R
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):1031-7. PubMed ID: 7811534
[TBL] [Abstract][Full Text] [Related]
18. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.
Vitone F; Gibellini D; Schiavone P; Re MC
J Clin Virol; 2005 Jul; 33(3):194-200. PubMed ID: 15911440
[TBL] [Abstract][Full Text] [Related]
19. Highly divergent patterns of genetic diversity and evolution in proviral quasispecies from HIV controllers.
de Azevedo SSD; Caetano DG; Côrtes FH; Teixeira SLM; Dos Santos Silva K; Hoagland B; Grinsztejn B; Veloso VG; Morgado MG; Bello G
Retrovirology; 2017 May; 14(1):29. PubMed ID: 28464889
[TBL] [Abstract][Full Text] [Related]
20. Steady increase in cellular HIV-1 load during the asymptomatic phase of untreated infection despite stable plasma viremia.
Pasternak AO; Jurriaans S; Bakker M; Berkhout B; Lukashov VV
AIDS; 2010 Jul; 24(11):1641-9. PubMed ID: 20543660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
